Gene therapy had a hell of a 2017. After decades of promises but failed deliveries, last year saw the field hitting a series of astonishing home runs. Here’s how the tech grew into its explosive potential—and a sneak peek at what’s on the horizon for 2018.| SingularityHub
CAR-T is the revolutionary gene therapy the FDA has approved which allows for patient's own immune cells to be genetically engineered to fight cancer.| SingularityHub